Showing results (101-110 of 290) with videos related to
Sort By:
Pageof 29
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|October 23, 2020
Long-term outcomes of epoprostenol therapy in sarcoid associated pulmonary hypertensionEric Abston, Matthew Moll, Stephanie Hon, et al.Gastroenterology|December 18, 2019
Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With OutcomesCorinne Frere, Barbara Bournet, Sophie Gourgou, et al.Critical Pathways in Cardiology|December 18, 2020
Atrial Fibrillation Patients on Warfarin and Their Transition to Direct Oral AnticoagulantsPeter Collins, Andrea Lewin, Nicole Vincze Irving, et al.Critical Pathways in Cardiology|May 17, 2019
Andexanet Alfa (Andexxa) Formulary ReviewNahal Beik, Prabashni Reddy, Katelyn W Sylvester, et al.American Journal of Therapeutics|December 14, 2019
Activated Clotting Times Demonstrate Weak Correlation With Heparin Dosing in Adult Extracorporeal Membrane OxygenationBenjamin Hohlfelder, Daniel Kelly, Minh Hoang, et al.Journal of Thrombosis and Thrombolysis|March 10, 2015
Regulatory, legislative, and policy updates with anticoagulant useJohn Fanikos, Leo F Buckley, Ahmed Aldemerdash, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 8, 2019
Derivation and Validation of Age- and Body Mass Index-Adjusted Weight-Based Unfractionated Heparin DosingJames W Schurr, Anne-Marie Muske, Craig A Stevens, et al.Journal of Thrombosis and Thrombolysis|July 12, 2020
Evaluation and optimization of prescribed concomitant antiplatelet and anticoagulation therapy centrally managed by an anticoagulation management serviceSara A Zekery-Saad, Andrea Lewin, Magie Pham, et al.Critical Pathways in Cardiology|November 13, 2020
Development of an Institutional Periprocedural Management Guideline for Oral AnticoagulantsAndrea R Lewin, Peter E Collins, Katelyn W Sylvester, et al.Journal of Thrombosis and Thrombolysis|May 23, 2018
Four factor prothrombin complex concentrate for warfarin reversal in patients with left ventricular assist devicesJessica Rimsans, Amy Levesque, Erin Lyons, et al.Pageof 29